We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Keras Resources Plc | LSE:KRS | London | Ordinary Share | GB00BMY2T534 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.70 | 1.50 | 1.90 | 1.70 | 1.70 | 1.70 | 640,000 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Iron Ores | 994k | -1.08M | -0.0134 | -1.27 | 1.36M |
From Apr 2019 to Apr 2024
TIDMKRS
RNS Number : 7377F
Keras Resources PLC
22 May 2017
Keras Resources plc / Index: AIM / Epic: KRS / Sector: Mining
22 May 2017
Keras Resources plc
("Keras" or the "Company")
Interim Results
Keras Resources plc, the AIM listed mineral resource company, is pleased to announce its interim results for the six months ended 31 March 2017.
HIGHLIGHTS
Development of a strategic multi-commodity mining portfolio:
-- Targeting listing of Australian gold assets on the ASX in June 2017 to establish a standalone listed entity on a market which has demonstrated significant interest for domestic resource projects:
o Completed the acquisition of the Klondyke gold project ("Klondyke") in October 2016, subsequently expanded to form the Warrawoona Gold Project ('Warrawoona');
o Established significant gold inventory of 5.8Mt @ 2.2g/t gold for 410,000oz with significant further upside;
o ASX quoted Pharmanet Group Limited ('Pharmanet') to acquire 100% of Keras Australia and change name to Calidus Resources (the "Transaction");
o Oversubscribed placing from sophisticated investors in Australia raised A$620,000 for Pharmanet - underpinning support for the Transaction;
o General meeting of Keras shareholders to be held in the UK on 24 May 2017 to approve the Transaction; and
o Pharmanet to raise A$7.9 million with the re-listing of Calidus Resources on the ASX in June 2017.
-- Gaining exposure to the high-growth battery industry through the development of three complementary commodities in Togo: cobalt, nickel and manganese:
o Awaiting mining licence for 11.0Mt @ 13.1% manganese Nayega project - seeking to develop an initial open-pit, 250,000tpa manganese operation;
o Expanded mineral footprint through the application for five exploration licences, which have known cobalt and nickel mineralisation outcropping at surface:
-- Exploration underway;
-- Cobalt often reported as the most critical metal from a supply perspective for the battery industry - prices have increased 100% in the past six months.
-- Capital raisings of GBP600,000 (before expenses) in February 2017 to support ongoing exploration work at Warrawoona, and, of GBP530,000 (before expenses) in April 2017 to support the Transaction and the Group's manganese and cobalt projects.
Chairman's Statement
2017 to-date has been a year of change and development for Keras, centred around the planned listing of our Australian gold assets on the Australian Securities Exchange ('ASX'), which we believe will realise the potential of the projects and accordingly realise the best value for our shareholders. Alongside this, we have diversified our project portfolio having identified a significant opportunity to capitalise on commodities that are critical to the future expansion of the growing battery industry, which we believe are currently underrepresented - namely cobalt, nickel and manganese. With a restructured portfolio of strategic assets, I believe the remainder of 2017 is set to be equally active for the Company.
Looking first at the gold assets, I would like to take this opportunity to provide further information on our reasoning for listing our wholly owned subsidiary Keras (Gold) Australia Pty Ltd ('Keras Australia') on the ASX, through a shell company, Pharmanet Group Limited ('Pharmanet'). As shareholders will be aware, our primary focus over the past 12 months has been on advancing this gold portfolio both in terms of increasing our land holding and proving up the resource potential. I am pleased to report that we have had significant success in both respects, creating an enlarged Warrawoona Gold Project in the East Pilbara Gold Belt of the Pilbara Goldfield of Western Australia. Warrawoona has a total Inferred Mineral Resource Inventory of 5.8Mt @ 2.2g/t Au for 410,000oz with significant further upside. This includes Klondyke and the Copenhagen Deposit.
Whilst we continue to see significant potential for Warrawoona, we have held the view that these assets should be developed as a standalone entity, separate from our African interests. Furthermore, we hold the view that the ASX is a more suitable home for these assets. Accordingly, we set about identifying a suitable vehicle and structure to best realise value for shareholders.
As announced on 21 March 2017, ASX quoted Pharmanet has conditionally agreed to acquire 100% of Keras Australia in exchange for shares in Pharmanet and raise working capital on ASX. Assuming that the milestones specified in the agreement between Pharmanet and Keras are met, Keras will eventually own 724 million Pharmanet shares at an initial price of A$0.02. By utilising Pharmanet and building in milestones to be achieved before part of our shareholding is issued, we are showing our belief in the assets to new shareholders and ultimately, will maximise value for all shareholders. Keras board members Dave Reeves and Peter Hepburn-Brown will be appointed to the Board of Pharmanet as Managing Director and Non-executive Director respectively. Pharmanet will also repay the majority of the liability under the Company's Acquisition Finance Facility, as summarised in the Company's announcement of 12 September 2016.
Our decision to enter into the Transaction is already proving well-founded. Pharmanet has received strong interest from investors interested in Warrawoona, with Pharmanet raising A$620,000 before expenses (approximately GBP360,000) from sophisticated investors in Australia via an oversubscribed placing as announced on 18 April 2017. Pharmanet is now seeking to raise A$7.9 million (approximately GBP4.6 million) to rapidly advance the project by way of a major drilling and exploration programme and initial Scoping Studies. We will continue to keep shareholders updated with progress relating to this, but are pleased that milestone developments continue to be met on time and Pharmanet remains on track to relist as Calidus Resources Limited in June 2017.
With a strong balance sheet, experienced board and a defined development strategy, we believe Calidus is set to become one of the few independent near term gold development companies on the ASX. Accordingly, I firmly believe our strategic interest in Calidus will offer significant value exposure to Keras whilst removing the burden of capital commitments for project development.
The Transaction requires the approval of Keras shareholders, and the General Meeting to consider such approval has been convened for Wednesday, 24 May 2017. At today's date, proxy votes received are overwhelmingly in favour of the Transaction.
Looking to Africa, Keras retains an 85% interest in the Nayega Manganese Project in Togo, which we are confident can deliver significant value in the near-term. The project has a JORC Code Compliant Indicated and Measured Resource of 11.0Mt @ 13.1% manganese and we have completed the majority of the Phase 1 Definitive Feasibility Study to develop an initial open-pit, 250,000tpa manganese operation. To enable this proposed development, we have applied for a Mining Permit and are currently awaiting the award of this.
Building upon the positive relations we have built with the Togo Government, we are delighted to have recently increased our mineral footprint in country having been granted five exploration licences over vacant ground that covers known cobalt and nickel mineralisation. Average rock chips from the mineralised zone have recovered grades of 0.82% nickel ("Ni") and 0.19% cobalt ("Co"), with highs of 1.4% Ni and 0.25% Co. This equates to a 4.5g/t equivalent gold grade based on current metal prices.
We believe these new licences offer a strategic development opportunity for Keras, given current market dynamics which are placing significant demand on materials such as lithium, cobalt, nickel and manganese, which are critical to the rapidly growing battery market. Indeed, cobalt is often reported as the most critical metal from a supply perspective for this industry, with a substantial shortfall expected before 2020 unless additional capacity is bought online. Accordingly, prices have increased 100% in the past six months. With cobalt mineralisation already proven at our new licences, we hope to help address this supply/demand deficit. Initial exploration work consisting of mapping, sampling, trenching, alongside the compilation of historical data to prove up the resource potential is already underway, and we look forward to keeping the market updated with developments as we advance this exciting asset.
Financial Review
Keras has recorded a total comprehensive loss for the 6 months ended 31 March 2017 of GBP1,308,000. The loss was mainly associated with a small operating loss from the Wycheproof open pit project and expensing of exploration administrative support expenditure. Finance costs of GBP432,000 related primarily to the Finance Agreement described below.
Intangible assets increased to GBP3.5m at 31 March 2017. The main reason for the increase being the acquisition of in October 2016 of Klondyke. Consideration for the Klondyke acquisition was settled via the payment of A$1.42m (GBP0.8m) in cash, with the balance via the issue of 100,000,000 ordinary shares of 0.1p each ("Ordinary Shares") in the Company, at a price of 0.62p being the closing price on 4 October 2016 (the "Consideration Shares"). The Consideration Shares are subject to standard lock in and orderly market terms. In order to fund the Klondyke acquisition the Company has entered into an Acquisition Finance Facility Agreement ('Finance Agreement') with a consortium of investors arranged by Riverfort Global Capital Ltd (the 'Investors'). The total drawdown available before fees to the Company is US$2m (GBP1.5m) ('Principal Amount') with a maturity date six months after the initial drawdown at an interest rate of 10% per semi-annum, with a Commitment Fee and an Implementation Fee of 5% each. As announced on 28 April 2017, pursuant to the Company's plan to list the Australian gold assets on the ASX, the repayment date of this facility had been extended
to 1 July 2017.
In February 2017 Keras completed an equity raising of GBP600,000 (before expenses) to support ongoing exploration work at Warrawoona. Since the end of the period a further equity raising of GBP530,000 (before expenses) has been completed to provide working capital for the manganese and cobalt projects in Togo as well as costs relating to the Transaction.
Outlook
With exposure to cobalt, nickel and manganese, our African licences provide investors with strategic access to the high growth battery market. Alongside this, our plans to list our Australian gold assets in a standalone ASX quoted company provides a clear structure through which we can gain significant value exposure. With multiple value upside triggers and diverse commodity exposure combining the "safe-haven" of gold with the burgeoning battery market I believe Keras is well poised for growth.
We look forward to continuing to keep shareholders abreast of developments as we enter this next phase of our growth. I would like to thank our investors for their support and our board and management team for their consistent hard work.
Brian Moritz
Chairman
22 May 2017
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
**S**
For further information please visit www.kerasplc.com, follow us on Twitter @kerasplc or contact the following:
Dave Reeves Keras Resources plc dave@kerasplc.com Nominated Adviser Gerry Beaney/David Hignell Northland Capital Partners Limited +44 (0) 20 3861 6625 Broker Elliot Hance/Jonathon Belliss Beaufort Securities Limited +44 (0) 20 7382 8415 Damon Heath/Erik Woolgar Shard Capital Ltd +44 (0) 20 7186 9952 Tom Curran/Ben Tadd SVS Securities +44 (0) 20 3700 0093 Financial PR Susie Geliher/Charlotte Page St Brides Partners Limited +44 (0) 20 7236 1177
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTHSED 31 MARCH 2017
Hot Features
Premium
Re-presented Re-presented
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
GBP'000 GBP'000 GBP'000
Continuing operations
Revenue 941 - 1,936
Cost of
sales (1,048) - (2,242)
-------------- ------------- -------------
Gross
profit (107) - (306)
Administrative and
exploration expenses (604) (615) (1,223)
Loss from operating
activities (711) (615) (1,529)
Finance income - 40 -
Finance
costs (432) (416) (486)
Net finance costs (432) (376) (486)
Impairment of assets - - (10)
Loss before taxation (1,143) (991) (2,025)
Taxation - 135 (117)
-------------- ------------- -------------
Loss from continuing
operations (1,143) (856) (2,142)
-------------- ------------- -------------
Discontinued operations
Loss from discontinued
operations, net of tax 7 (3) (61) (97)
Loss (1,146) (917) (2,239)
Other comprehensive
income
Exchange translation on foreign
operations (162) 167 95
-------------- ------------- -------------
Other comprehensive (loss)/income
for the period, net of tax (162) 167 95
-------------- ------------- -------------
Total comprehensive
loss for the period (1,308) (750) (2,144)
============== ============= =============
Loss attributable
to:
Owners of the Company (2,055) (894) (2,211)
Non-controlling interests 909 (23) (28)
-------------- ------------- -------------
Loss for the year (1,146) (917) (2,239)
============== ============= =============
Total comprehensive
loss attributable to:
Owners of the Company (2,196) (718) (2,075)
Non-controlling interests 888 (32) (69)
-------------- ------------- -------------
Total comprehensive
loss for the year (1,308) (750) (2,144)
============== ============= =============
Loss per share - continuing
operations
Basic and diluted
loss per share (pence) (0.135) (0.076) (0.176)
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2017
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
Notes GBP'000 GBP'000 GBP'000
Assets
Non-current assets
Intangible assets 8 3,491 2,361 2,041
Property, plant and
equipment 10 41 34 51
Trade and other receivables 11 29 145 29
3,561 2,540 2,121
------------- ------------- -----------
Current assets
Inventory 12 - - 604
Trade and other receivables 11 26 75 200
Cash and cash equivalents 143 155 134
------------- ------------- -----------
169 230 938
------------- ------------- -----------
Total assets 3,730 2,770 3,059
============= ============= ===========
Equity
Equity attributable to owners
of the Company
Share capital 13 6,494 5,983 6,123
Share premium 13 8,849 6,427 7,666
Other reserves (31) 260 (339)
Retained deficit (14,591) (11,597) (12,387)
------------- ------------- -----------
721 1,073 1,063
Non-controlling interests (142) (693) (730)
------------- ------------- -----------
Total equity 579 380 333
------------- ------------- -----------
Liabilities
Current liabilities
Loans and borrowings 14 2,011 1,036 1,136
Trade and other payables 15 1,140 1,354 1,590
3,151 2,390 2,726
------------- ------------- -----------
Total liabilities 3,151 2,390 2,726
------------- ------------- -----------
Total equity and liabilities 3,730 2,770 3,059
============= ============= ===========
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHSED 31 MARCH 2016
Total attributable to owners of the
Company
Share
option/ Foreign Non-controlling
Share Share warrant exchange Accumulated interests Total
capital premium reserve reserve losses Total GBP'000 equity
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1
October
2015 (audited) 5,504 6,371 250 273 (11,275) 1,123 (661) 462
Loss for the
period - - - - (894) (894) (23) (917)
Total other
comprehensive
income - - - (146) 322 176 (9) 167
--------- --------- -------- ---------- ------------- ---------- ----------------- ---------
Total
comprehensive
loss for the
period - - - (146) (572) (718) (32) (750)
Issue of
ordinary
shares 479 56 - - - 535 - 535
Transfer
reserve on
cancellation
of options - - (250) - 250 - - -
Warrants issued
in lieu
of finance
costs - - 133 - - 133 - 133
479 56 (117) - 250 668 - 668
Balance at 31
March
2016
(unaudited) 5,983 6,427 133 127 (11,597) 1,073 (693) 380
========= ========= ======== ========== ============= ========== ================= =========
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (CONTINUED)
FOR THE SIX MONTHSED 30 SEPTEMBER 2016
Total attributable to owners of the
Company
Share
option/ Exchange Retained Total Non-controlling
Share Share warrant reserve deficit interests Total
capital premium reserve GBP'000 equity
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1
April 2016
(unaudited) 5,983 6,427 133 127 (11,597) 1,073 (693) 380
Loss for the
period - - - (839) (478) (1,317) (5) (1,322)
Total other
comprehensive
income - - - 307 (347) (40) (32) (72)
--------- --------- -------- ---------- ---------- ---------- ----------------- ---------
Total
comprehensive
loss for the
period - - - (532) (825) (1,357) (37) (1,394)
Issue of
ordinary
shares 140 1,250 - - - 1,390 - 1,390
Issue costs - (11) - - - (11) - (11)
Warrants issued
in lieu
of finance
costs - - (32) - - (32) (32)
Transfer in
respect
of warrants
exercised - - (35) - 35 - - -
--------- --------- -------- ---------- ---------- ---------- ----------------- ---------
140 1,239 (67) - 35 1,347 - 1,347
Balance at 30
September
2016 (audited) 6,123 7,666 66 (405) (12,387) 1,063 (730) 333
========= ========= ======== ========== ========== ========== ================= =========
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (CONTINUED)
FOR THE SIX MONTHSED 31 MARCH 2017
Total attributable to owners of the
Company
Share
option/ Foreign Non-
Share Share warrant exchange Accumulated controlling Total
capital premium reserve reserve losses Total interests equity
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1
October
2016 (audited) 6,123 7,666 66 (405) (12,387) 1,063 (730) 333
Loss for the
period - - - - (2,055) (2,055) 909 (1,146)
Total other
comprehensive
income - - - (45) (96) (141) (21) (162)
--------- --------- -------- ---------- ------------- ---------- ------------- ---------
Total
comprehensive
loss for the
period - - - (45) (2,151) (2,196) 888 (1,308)
Issue of
ordinary
shares 371 1,219 - - - 1,590 - 1,590
Issue costs - (36) - - - (36) - (36)
Share based - - - - - - - -
payment
transactions
Disposal of
subsidiaries
with NCI - - - 353 (53) 300 (300) -
--------- --------- -------- ---------- ------------- ---------- ------------- ---------
371 1,183 - 353 (53) 1,854 (300) 1,554
Balance at 31
March
2017
(unaudited) 6,494 8,849 66 (97) (14,591) 721 (142) 579
========= ========= ======== ========== ============= ========== ============= =========
KERAS RESOURCES PLC
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHSED 31 MARCH 2017
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
GBP'000 GBP'000 GBP'000
Cash flows from operating
activities
Loss for the period (including
discontinued activities) (714) (676) (1,626)
Adjustments for:
Depreciation and amortisation 72 7 107
Loss on disposal of property, 15 - -
plant and equipment
Foreign exchange differences (221) 17 (90)
Equity-settled share-based - - -
payment transactions
------------- ------------- -----------
(848) (652) (1,609)
Changes in:
- inventories 604 - (604)
- trade and other receivables 174 (23) (177)
- trade and other payables (685) 359 942
------------- ------------- -----------
Cash used in operating
activities (755) (316) (1,448)
Finance income - - -
Finance cost (281) (31) (344)
Taxes paid (69) - -
------------- ------------- -----------
Net cash used in operating
activities (350) (347) (1,792)
------------- ------------- -----------
Cash flows from investing
activities
Acquisition of property,
plant and equipment (2) - (21)
Proceeds from sale of property, - - -
plant and equipment
Exploration expenditure (847) (81) (286)
Net cash used in investing
activities (849) (81) (307)
------------- ------------- -----------
Cash flows from financing
activities
Net proceeds from issue
of share capital 600 70 1,434
Proceeds from short
term borrowings 1,362 449 735
Net cash flows from
financing activities 1,962 519 2,169
------------- ------------- -----------
Net (decrease)/increase
in cash and cash equivalents 8 91 70
Cash and cash equivalents
at beginning of period 134 64 64
Cash acquired with 1 - -
subsidiary
Effect of foreign exchange - - -
rate changes
------------- ------------- -----------
Cash and cash equivalents
at end of period 143 155 134
============= ============= ===========
KERAS RESOURCES PLC
NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
FOR THE SIX MONTHSED 31 MARCH 2017
1. Reporting entity
Keras Resources plc is a company domiciled in England and Wales. The condensed consolidated interim financial statements of the Company as at and for the six months ended 31 March 2017 comprise the Company and its subsidiaries (together referred to as the "Group") and the Group's interests in associates and jointly controlled entities. The Group currently operates as an explorer and developer and commenced production at its Australian gold projects in 2016.
2. Basis of preparation (a) Statement of compliance
This condensed consolidated interim financial report has been prepared in accordance with IAS 34 Interim Financial Reporting. Selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in financial performance and position of the Group since the last annual consolidated financial statements as at and for the year ended 30 September 2016. This condensed consolidated interim financial report does not include all the information required for full annual financial statements prepared in accordance with International Financial Reporting Standards.
This condensed consolidated interim financial report was approved by the Board of Directors on 19 May 2017.
(b) Judgements and estimates
Preparing the interim financial report requires Management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.
In preparing this condensed consolidated interim financial report, significant judgements made by Management in applying the Group's accounting policies and key sources of estimation uncertainty were the same as those that applied to the consolidated financial statements as at and for the year ended 30 September 2016.
3. Significant accounting policies
The accounting policies applied by the Group in this condensed consolidated interim financial report are the same as those applied by the Group in its consolidated financial statements as at and for the year ended 30 September 2016.
4. Financial instruments
Financial risk management
The Group's financial risk management objectives and policies are consistent with those disclosed in the consolidated financial statements as at and for the year ended 30 September 2016.
5. Segment information
The Group considers that it operates in two distinct business areas, being that of manganese exploration and that of gold exploration and extraction. The extraction of iron ore is now considered to be a discontinued activity. These business areas form the basis of the Group's operating segments. For each segment, the Group's Managing Director (the chief operating decision maker) reviews internal management reports on at least a quarterly basis.
Other operations relate to the group's administrative functions conducted at its head office and by its intermediate holding company together with consolidation adjustments.
Information regarding the results of each reportable segment is included below. Performance is measured based on segment profit before tax, as included in the internal management reports that are reviewed by the Group's Managing Director. Segment results are used to measure performance as management believes such information is the most relevant in evaluating the performance of certain segments relative to other entities that operate within these industries.
For the six months ended 31 March 2017 (unaudited)
Discontinued Other
Gold Iron Manga-nese Segments Total
GBP'000 Ore GBP'000 GBP'000 GBP'000
GBP'000
External revenue 941 - - - 941
========== ============= ============= ========== ==========
Loss before tax (263) (3) (34) (846) (1,146)
========== ============= ============= ========== ==========
Segment assets 2,667 - 559 504 3,730
========== ============= ============= ========== ==========
For the six months ended 31 March 2016 (unaudited)
Discontinued Other
Gold Iron Manga-nese Segments Total
GBP'000 Ore GBP'000 GBP'000 GBP'000
GBP'000
External revenue - - - - -
========== ============= ============= ========== ==========
Loss before tax (244) (61) (30) (717) (1,052)
========== ============= ============= ========== ==========
Segment assets 1,317 35 892 526 2,770
========== ============= ============= ========== ==========
For the twelve months ended 30 September 2016 (audited)
Discontinued Other
Gold Iron Manga-nese Segments Total
GBP'000 Ore GBP'000 GBP'000 GBP'000
GBP'000
External revenue 1,936 - - - 1,936
========== ============= ============= ========== ==========
Loss before tax (830) (97) (108) (1,087) (2,122)
========== ============= ============= ========== ==========
Segment assets 1,941 22 575 521 3,059
========== ============= ============= ========== ==========
:
5. Segment information (continued)
Information about geographical
segments:
For the six months ended 31 March 2017 (unaudited)
Discontin-ued West Other
Australia South Africa* Segments Total
GBP'000 Africa GBP'000 GBP'000 GBP'000
GBP'000
External revenue 941 - - - 941
============ ============== ========= ========== ==========
Profit/(loss)
before tax (263) - (37) (846) (1,146)
============ ============== ========= ========== ==========
Segment assets 2,667 - 559 504 3,730
============ ============== ========= ========== ==========
*Information regarding West Africa includes GBP3,000
loss before tax and GBPnil segment assets relating
to discontinued activities.
For the six months ended 31 March 2016 (unaudited)
Discontin-ued West Other
Australia South Africa* Segments Total
GBP'000 Africa GBP'000 GBP'000 GBP'000
GBP'000
External revenue - - - - -
============ ============== ========= ========== ==========
Loss before tax (206) (18) (105) (723) (1,052)
============ ============== ========= ========== ==========
Segment assets 1,688 9 547 526 2,770
============ ============== ========= ========== ==========
*Information regarding West Africa includes GBP43,000
loss and GBP26,000 segment assets relating to
discontinued activities.
For the twelve months ended 30
September 2016 (audited)
Discontin-ued West Other
Australia South Africa* Segments Total
GBP'000 Africa GBP'000 GBP'000 GBP'000
GBP'000
External revenue 1,936 - - - 1,936
============ ============== ========= ========== ==========
Loss before tax (830) (12) (184) (1,096) (2,122)
============ ============== ========= ========== ==========
Segment assets 1,940 8 589 522 3,059
============ ============== ========= ========== ==========
*Information regarding West Africa includes GBP85,000
loss and GBP14,000 segment assets relating to
discontinued activities.
6. Seasonality of operations
The Group is not considered to be subject to seasonal fluctuations.
7. Discontinued operations
On 17 February 2017 the Group applied to deregister its South African subsidiary, Moongate 218 (Pty) Limited. An application for deregistration of Southern Mn (Pty) Ltd will be made in due course. On 6 January 2017, the Group disposed of its entire 78.3% interest in Ressource Equatoriales SARL for nil consideration. These actions were taken by the Group as either the licences had expired or it was considered that the operations were no longer viable for the Group. The Group no longer holds iron ore assets. The comparative consolidated statement of profit or loss and OCI have been represented to show the discontinued operations separately from continuing operations.
Results of discontinued operations
6 months 6 months 12 months
31-Mar-17 31-Mar-16
(unaudited) (unaudited) 30-Sep-16
GBP'000 GBP'000 (audited)
GBP'000
Revenue - - -
Cost of sales - - -
------------- -------------- ------------
Gross profit - - -
Administrative and exploration
expenses (3) (61) (97)
Loss from operating
activities (3) (61) (97)
Finance income - - -
Finance costs - - -
Net finance costs - - -
Impairment of assets - - -
Loss before taxation (3) (61) (97)
Taxation - - -
------------- -------------- ------------
Loss from discontinued
operations (3) (61) (97)
------------- -------------- ------------
Cash flows from (used in) discontinued operation
6 months 6 months 12 months
31-Mar-17 31-Mar-16
(unaudited) (unaudited) 30-Sep-16
GBP'000 GBP'000 (audited)
GBP'000
Net cash used in operating - - -
activities
Net cash from investing - - -
activities
------------- -------------- ------------
Net cash flows for - - -
the period
------------- -------------- ------------
7. Discontinued operations (continued)
Effect of disposal on the financial position of the Group
GBP'000
Property, plant and
equipment 15
Trade and other receivables 1
Cash and cash equivalents -
Trade and other payables -
Net assets and liabilities 16
========
Consideration received -
Net cash inflows -
8. Intangible assets
6 months 6 months 12 months
31 Mar 31 Mar 30 Sep
17 16 (unaudited) 16
(unaudited) GBP'000 (audited)
GBP'000 GBP'000
Cost
Balance at beginning of period 6,686 5,590 5,590
Additions 1,631 1,050 790
Disposals (4,705) - -
Effect of movement in exchange
rates 60 140 306
------------- ---------------- -----------
Balance at end of period 3,672 6,780 6,686
============= ================ ===========
Impairment losses
Balance at beginning of period 4,645 4,419 4,419
Impairment - - 10
Amortisation 65 - 88
Disposals (4,532)
Effect of movement in exchange
rates 3 - 128
------------- ---------------- -----------
Balance at end of period 181 4,419 4,645
============= ================ ===========
Carrying amounts
Balance at end of period 3,491 2,361 2,041
====== ====== ======
Balance at beginning of period 2,041 1,171 1,171
====== ====== ======
Intangible assets comprise the fair value of mineral exploration rights acquired, the cost of explorations studies and goodwill.
9. Business combinations
On 5 October 2016, the Group acquired 100 per cent of the ordinary share capital of Arcadia Minerals Pty Limited (now renamed Keras (Pilbara) Gold Pty Limited), an Australian registered private company. The acquisition was settled by way of cash and a share issue. The acquisition related to the Klondyke Gold Project.
The transaction has been accounted for using the acquisition method of accounting.
The details of the business combination are as follows:
Fair
Book value value Fair
GBP'000 adjustments value
GBP'000 GBP'000
Mineral rights 266 1,145 1,411
Fixed assets 8 - 8
Bank balances and
cash 1 - 1
275 1,145 1,420
============= ============= ==========
GBP'000
Satisfied by:
Cash 800
Share consideration 620
1,420
========
10. Property, plant and equipment
Acquisitions and disposals
During the six months ended 31 March 2017 the Group acquired assets with a cost of GBP10,000 (six months ended 31 March 2016: GBP6,000, twelve months ended 30 September 2016: GBP27,000).
Assets with a carrying amount of GBP15,000 were disposed of during the six months ended 31 March 2016 (six months ended 31 March 2016: GBPnil; twelve months ended 30 September 2016: GBPnil), resulting in a loss on disposal of GBP15,000 (six months ended 31 March 2016: GBP2,000; twelve months ended 30 September 2016: GBPnil), which is included in 'administrative expenses' in the condensed consolidated statement of comprehensive income.
11. Trade and other receivables
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
Other receivables 41 47 37
Prepayments 14 - 15
55 47 52
============= ============= ===========
Trade receivables and other receivables are stated at their nominal values less allowances for non recoverability.
12. Inventories
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
Minerals held for sale - - 426
Production stockpile - - 178
- - 604
=================== =================== ===========
13. Share capital and reserves
Issue of ordinary shares
On 5 October 2016, 100,000,000 ordinary shares were issued at GBP0.0062 per share as part of the acquisition of the Klondyke Gold Project.
On 26 January 2017, 171,428,571 ordinary shares were issued for cash at GBP0.0035 per share.
On 21 February 2017 99,810,827 ordinary shares were issued at GBP0.0037 per share in part settlement of the unsecured loan notes with 8% redemption as detailed in note 14, the balance being settled in cash.
Warrants
On 5 October 2017, in connection with the finance agreement set up to acquire the Klondyke Gold Project, GBP389,350 worth of warrants were granted at a strike price of GBP0.8501, these are valid for two years from the date of issue.
Dividends
No dividends were declared or paid in the six months ended 31 March 2017 (period ended 31 March 2016: GBPnil, year ended 30 September 2016: GBPnil).
14. Loans and borrowings
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited)
(unaudited) (audited)
Unsecured loan notes - 10% 314 314 314
Unsecured loan notes - 8%
redemption - 457 556
Non-convertible loan 133 265 266
Acquisition Finance facility 1,564 - -
2,011 1,036 1,136
============= ============= ===========
The loan notes carry interest at 10% per annum and are repayable on demand. This loan was provided to the Company by the Managing Director David Reeves.
The non-convertible loan relates to the closure of the equity swap agreement. It is unsecured and was originally scheduled for repayment on 17 February 2017. This has been extended and is anticipated to be repaid by June 2017.
The Acquisition Finance Facility Agreement was entered into as a bridge funding facility to acquire the Klondyke Gold Project. It's maturity date is six months after initial drawdown, being 3 October 2016, and, prior to maturity, the lender may elect to convert such principal amount of the loan outstanding at a 20% premium to the Company's closing share price on the date of drawdown. On 20 March 2017 the Company and the lender agreed to defer repayment of this facility to the 3 June 2017. A further agreement to defer repayment up to 1 July 2017 was entered into on the 27 April 2017.
15. Trade and other payables
31-Mar-17 31-Mar-16 30-Sep-16
(unaudited) (unaudited) (audited)
Trade payables 471 633 496
Accruals 618 256 579
Other payables 51 465 515
1,140 1,354 1,590
============= ============= ===========
There is no material difference between the fair value of trade and other payables and their book value.
16. Subsequent events
On 21 March 2017, the Group announced its plans for the proposed listing of the Company's Australian gold assets on the ASX, this is subject to obtaining all necessary approvals but it is anticipated that the listing will take place in Q2 2017. On 8 May 2017 the Group announced that ASX quoted Pharmanet lodged a prospectus with the Australian Securities and Investments Commission (the "Prospectus") on 5 May 2017. The Prospectus has been lodged in order to raise A$7.9 million (approximately GBP4.6 million) as part of the proposed acquisition by Pharmanet of 100% of the issued share capital of the Company's wholly owned subsidiary Keras Australia as previously announced on 21 March 2017. Pharmanet is anticipated to relist as Calidus in June 2017.
On 24 April 2017, the Group raised GBP530,000 (before expenses) from new and existing shareholders through the placing of 151,428,560 ordinary shares of 0.1p each ('Ordinary Shares') at a placing price of 0.35p per Ordinary Share (the 'Placing Shares') and the grant of 75,714,280 warrants to subscribe for new Ordinary Shares (the 'Placing Warrants') (together the 'Placing'). The Placing Warrants are exercisable at price of 0.5p per warrant, within a 2-year exercise period and the Placing Warrants are conditional on passing of the shareholder resolutions at a forthcoming General Meeting.
On 28 April 2017, the Group announced that it would be holding a general meeting for Shareholders on the 24 May 2017 relating to the proposed acquisition of by Pharmanet of 100% of the issued share capital of the Company's wholly owned subsidiary Keras Australia as previously announced on 21 March 2017.
The Company also announced an extension to the US$2 million Acquisition Finance Facility Agreement with the Investors as originally announced on 12 September 2016. On 21 March 2017 the Company announced that the maturity date of the Acquisition Finance Facility had been extended until 3 June 2017 (the "Deferral Agreement"). The Deferral Agreement was subsequently amended on 28 April 2017 to extend the maturity date by a further month until 1 July 2017 to allow time for the Transaction to complete.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IR LLFIFEEILFID
(END) Dow Jones Newswires
May 22, 2017 02:00 ET (06:00 GMT)
1 Year Keras Resources Chart |
1 Month Keras Resources Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
